Skip to main content

Table 3 Male and female group comparisons of hdl-cholesterol, triglycerides and vitamin d at different time points

From: Vitamin D supplementation in patients with diabetes mellitus type 2 on different therapeutic regimens: a one-year prospective study

HDL(mmol/l)

Control

Rosiglitazone

Diet

Insulin

Insulin + Orals

Metformin

Oral agents combination

Sulphonylurea

Male

Baseline

0.57 ± 0.05

0.94 ± 0.06

0.99 ± 0.22

0.94 ± 0.08

0.81 ± 0.18

0.92 ± 0.06

0.93 ± 0.11

0.92 ± 0.09

6 months

0.92 ± 0.09*

1.0 ± 0.17

-

1.0 ± 0.17

0.86 ± 0.26

0.81 ± 0.13

1.1 ± 0.26

1.0 ± 0.17

12 months

0.94 ± 0.15*

0.97 ± 0.13

-

0.88 ± 0.12

1.1 ± 0.32*

0.72 ± 0.19

0.88 ± 0.30

0.98 ± 0.28

Female

Baseline

0.76 ± 0.03

0.88 ± 0.22

1.1 ± 0.07

1.1 ± 0.04

1.0 ± 0.09

0.96 ± 0.03

1.0 ± 0.05

0.99 ± 0.04

6 months

1.0 ± 0.06*

-

1.0 ± 0.16

1.0 ± 0.13

1.0 ± 0.15

1.0 ± 0.05

1.2 ± 0.13

1.0 ± 0.07

12 months

0.99 ± 0.06*

-

 

1.2 ± 0.08

1.0 ± 0.17

1.1 ± 0.07

1.1 ± 0.10

1.1 ± 0.09

Triglycerides (mmol/l)

Male

Baseline

1.3 ± 0.03

2.3 ± 0.04

1.6 ± 0.16

1.7 ± 0.06

2.7 ± 0.13

2.1 ± 0.04

2.3 ± 0.08

2.2 ± 0.06

6 months

1.2 ± 0.06

1.5 ± 0.04*

1.1 ± 0.21

1.9 ± 0.09

1.7 ± 0.13*

2.4 ± 0.07

1.6 ± 0.09*

1.8 ± 0.07

12 months

1.4 ± 0.07

1.5 ± 0.07*

1.3 ± 0.22

1.7 ± 0.10

2.2 ± 0.12

2.3 ± 0.07

1.5 ± 0.12*

2.0 ± 0.11

Female

Baseline

1.2 ± 0.03

2.5 ± 0.28

1.6 ± 0.08

1.9 ± 0.05

2.1 ± 0.11

1.7 ± 0.04

1.8 ± 0.06

1.9 ± 0.05

6 months

1.3 ± 0.08

-

1.5 ± 0.12

1.8 ± 0.07

2.1 ± 0.13

1.8 ± 0.05

1.9 ± 0.09

2.2 ± 0.06

12 months

1.2 ± 0.06

-

1.8 ± 0.20

1.3 ± 0.08

1.7 ± 0.13*

1.6 ± 0.06

1.6 ± 0.10

2.0 ± 0.07

Vitamin D (nmol/l)

Male

Baseline

21.6 ± 1.0

33.7 ± 1.0

25.3 ± 1.0

34.9 ± 1.0

35.1 ± 1.0

35.7 ± 1.0

34.5 ± 1.0

34.5 ± 1.0

6 months

30.8 ± 1.0*

48.4 ± 1.0*

39.1 ± 1.1*

57.6 ± 1.1*

52.8 ± 1.2*

60.6 ± 1.1*

49.6 ± 1.1*

49.6 ± 1.1*

12 months

30.2 ± 1.1*

50.4 ± 1.1*

23.1 ± 1.0

50.1 ± 1.1*

45.8 ± 1.1*

54.5 ± 1.0*

53.7 ± 1.0*

53.1 ± .1.1*

Female

Baseline

17.6 ± 1.0

19.2 ± 1.0

24.0 ± 1.0

29.6 ± 1.0

33.2 ± 1.0

34.7 ± 1.0

34.6 ± 1.1

40.4 ± 1.0

6 months

24.2 ± 1.0

-

33.3 ± 1.1

53.5 ± 1.1*

59.1 ± 1.0*

66.0 ± 1.2*

42.1 ± 1.2*

54.5 ± 1.1*

12 months

22.6 ± 1.0

-

29.2 ± 1.0

45.4 ± 1.1*

49.1 ± 1.0*

57.9 ± 1.1*

42.9 ± 1.2*

46.8 ± 1.0*

  1. Data represented by Mean ± standard error; ‘*’ Represents significant difference from the baseline. Level of significance is at p ≤ 0.05.
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840